Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Peyronie’s disease

IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease

IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
p p Read More

Perovial is the first ever hyaluronic acid injectable treatment to be licensed for acute Peyronie’s disease

February 3, 2026 IBSA, News, Peyronie's disease
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy